Tokyo Tape
Sign in
← Taiko Pharmaceutical

Quarterly report · Q2

4574.TEDINET S100RMXK
Period2023-01-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥2.5bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥5.0bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥1.9bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income−¥396m2023-01-01 → 2023-06-30Cons.Operating income
Operating income−¥2.4bn2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income−¥510m2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income−¥3.4bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥2.5bn2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥492m2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax−¥2.8bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥514m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥4.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥2.8bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥514m2023-01-01 → 2023-06-30Cons.Profit loss
Net income−¥2.8bn2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥15.6bnat 2023-06-30Cons.Assets
Total assets¥15.0bnat 2022-12-31Cons.Assets
Total assets¥17.4bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥6.5bnat 2023-06-30Cons.Liabilities
Total liabilities¥7.0bnat 2022-12-31Cons.Liabilities
Net assets / equity¥9.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥8.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥10.2bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥4.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥3.1bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥4.5bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.4bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow¥126m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥2.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥631m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow¥707m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow¥190m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥96m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥827m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥997m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥501m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-11.362023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.762023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-112.262022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-64.172022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-24.052022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio58.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio53.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Otherother segmentsrevenue2023-01-01 → 2023-06-30¥2m
Otherother segmentsrevenue external2023-01-01 → 2023-06-30¥2m
Otherother segmentssegment profit2023-01-01 → 2023-06-30−¥11m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥492m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥370m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥370m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥407m
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥2.1bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥2.1bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥514m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥2.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥95m
Otherother segmentsrevenue2022-01-01 → 2022-06-30¥4m
Otherother segmentsrevenue external2022-01-01 → 2022-06-30¥4m
Otherother segmentssegment profit2022-01-01 → 2022-06-30−¥11m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥645m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥365m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥365m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥1.6bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.5bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.5bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥117m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30−¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Raw materials and suppliesPrior1YearInstant658000000JPY
Raw materials and suppliesCurrentQuarterInstant516000000JPY
Other caPrior1YearInstant299000000JPY
Other caCurrentQuarterInstant206000000JPY
Current assetsPrior1YearInstant7556000000JPY
Current assetsCurrentQuarterInstant8514000000JPY
Buildings and structures netPrior1YearInstant2234000000JPY
Buildings and structures netCurrentQuarterInstant2133000000JPY
Machinery equipment and vehicles netPrior1YearInstant2044000000JPY
Machinery equipment and vehicles netCurrentQuarterInstant1887000000JPY
LandPrior1YearInstant1807000000JPY
LandCurrentQuarterInstant1818000000JPY
Construction in progressPrior1YearInstant6000000JPY
Construction in progressCurrentQuarterInstant12000000JPY
Other net ppePrior1YearInstant303000000JPY
Other net ppeCurrentQuarterInstant262000000JPY
Property plant and equipmentPrior1YearInstant6397000000JPY
Property plant and equipmentCurrentQuarterInstant6113000000JPY
Intangible assetsPrior1YearInstant222000000JPY
Intangible assetsCurrentQuarterInstant177000000JPY
Investment securitiesPrior1YearInstant533000000JPY
Investment securitiesCurrentQuarterInstant506000000JPY
Other ioaPrior1YearInstant336000000JPY
Other ioaCurrentQuarterInstant323000000JPY
Investments and other assetsPrior1YearInstant869000000JPY
Investments and other assetsCurrentQuarterInstant830000000JPY
Noncurrent assetsPrior1YearInstant7489000000JPY
Noncurrent assetsCurrentQuarterInstant7121000000JPY
AssetsPrior1YearInstant15046000000JPY
AssetsCurrentQuarterInstant15636000000JPY
Notes and accounts payable tradePrior1YearInstant274000000JPY
Notes and accounts payable tradeCurrentQuarterInstant350000000JPY
Current portion of long term loans payablePrior1YearInstant1039000000JPY
Current portion of long term loans payableCurrentQuarterInstant969000000JPY
Accounts payable otherPrior1YearInstant554000000JPY
Accounts payable otherCurrentQuarterInstant960000000JPY
Income taxes payablePrior1YearInstant17000000JPY
Income taxes payableCurrentQuarterInstant19000000JPY
Refund liabilities clPrior1YearInstant94000000JPY
Refund liabilities clCurrentQuarterInstant66000000JPY
Provision for bonusesPrior1YearInstant23000000JPY
Provision for bonusesCurrentQuarterInstant53000000JPY
Provision for surcharge clPrior1YearInstant607000000JPY
Provision for surcharge clCurrentQuarterInstant－JPY
Asset retirement obligations clPrior1YearInstant－JPY
Asset retirement obligations clCurrentQuarterInstant186000000JPY
Other clPrior1YearInstant181000000JPY
Other clCurrentQuarterInstant282000000JPY
Current liabilitiesPrior1YearInstant2793000000JPY
Current liabilitiesCurrentQuarterInstant2888000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass